Do Modeling and Simulation Tools Really Benefit the Biosimilar In

July 28, 2022 - BioPharm
modeling and simulation

Recombinant Adeno-Associated Virus Type 5 Production Process
July 28, 2022 - Cytiva laboratory biopharma

Working With Advanced Therapeutics: You Bring the Idea, We Bring

July 28, 2022 - Cytiva advanced therapy

Developing a Robust Bioprocess Using Mechanistic Models
July 28, 2022 - Cytiva robust model

Alkaline stability of Fc and VH3 binding in protein A resins
June 30, 2022 - Cytiva

In the developm

Simulating chromatography processes in the growing molecular dive

June 30, 2022 - Cytiva

The increasing complexity and diversity of development pipel

Need solutions for large-scale production of mRNA-based molecules

June 30, 2022 - Cytiva

Therapies based on messenger RNA, such as mRNA vaccines, have r

Bispecific Antibodies are Moving from Research to Clinical Develo

June 30, 2022 - BioPharm

With recent approvals of bispecific antibodies, these complex m

Rethinking ion exchange chromatography modeling
June 16, 2022 - Cytiva

New to mRNA manufacturing? Here's what you need to know
June 16, 2022 - Cytiva

Next Page